Clinical Trial Detail

NCT ID NCT03274661
Title Pembrolizumab Activity in Patients With HR Competent and Deficient Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Baptist Health South Florida
Indications

Advanced Solid Tumor

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.